ReviewVirology journal2026
Cellular receptors and host factors mediating orthoflavivirus entry.
Review in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Orthoflaviviruses are positive-sense, enveloped RNA viruses that include dengue virus (DENV), Zika virus (ZIKV), yellow fever virus (YFV), West Nile virus (WNV), and Japanese encephalitis virus (JEV). Viral entry is a multistep process governed by the envelope (E) glycoprotein, virion lipid composition, and host-cell molecules that act at distinct mechanistic stages. A major limitation of the current literature is that attachment factors, internalization receptors, immune-modulatory receptors, and membrane-associated cofactors are often collectively termed "receptors", which can obscure the strength and interpretation of the underlying evidence. This review therefore reorganizes reported orthoflavivirus entry-associated molecules into four functional classes: attachment factors, bona fide or candidate internalization receptors, indirect immune-modulatory receptors, and membrane-associated or post-entry cofactors. We place particular emphasis on DENV because it imposes a major clinical burden among orthoflaviviruses and has been the subject of the most extensive receptor-related research. By integrating evidence from binding assays, genetic loss-of-function studies, and in vivo models, this review highlights conserved and virus-specific entry mechanisms. This mechanism-based framework may guide the development of receptor decoys and host-targeting antivirals, although clinical translation will require rigorous validation of antiviral breadth, delivery, safety, and resistance potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.